SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
JDRF to Support ViaCyte, Inc. (Formerly Known as Novocell, Inc.)'s Development of Innovative Encapsulated Beta Cell Replacement Therapy for Diabetes